Oncogene - Table of Contents alert Volume 37 Issue 14

If you are unable to see the message below, click here to view.

TABLE OF CONTENTS Volume 37, Issue 14 In this issue Article Brief Communications Also new AOP Article LTBP3 promotes early metastatic events during cancer cell dissemination Elena I. Deryugina, Ewa Zajac, Lior Zilberberg, Tomoki Muramatsu, Grishma Joshi et al. Oncogene 2018 37 :1815 - 1829; January 19, 2018; 10.1038/s41388-017-0075-1 Abstract | Full Text The BET bromodomain inhibitor CPI203 overcomes resistance to ABT-199 (venetoclax) by downregulation of BFL-1/A1 in in vitro and in vivo models of MYC+/BCL2+ double hit lymphoma A. Esteve-Arenys, J. G. Valero, A. Chamorro-Jorganes, D. Gonzalez, V. Rodriguez et al. Oncogene 2018 37 :1830 - 1844; January 22, 2018; 10.1038/s41388-017-0111-1 Abstract | Full Text Genetic and pharmacologic abrogation of Snail1 inhibits acinar-to-ductal metaplasia in precursor lesions of pancreatic ductal adenocarcinoma and pancreatic injury Volker Fendrich, Frederike Jendryschek, Saskia Beeck, Max Albers, Matthias Lauth et al. Oncogene 2018 37 :1845 - 1856; January 25, 2018; 10.1038/s41388-017-0100-4 Abstract | Full Text FYN promotes mesenchymal phenotypes of basal type breast cancer cells through STAT5/NOTCH2 signaling node Ga-Hang Lee, Ki-Chun Yoo, Yoojeong An, Hae-June Lee, Minyoung Lee et al. Oncogene 2018 37 :1857 - 1868; January 19, 2018; 10.1038/s41388-017-0114-y Abstract | Full Text IGF1R signaling drives antiestrogen resistance through PAK2/PIX activation in luminal breast cancer Yinghui Zhang, Lynn Wester, Jichao He, Tamar Geiger, Marja Moerkens et al. Oncogene 2018 37 :1869 - 1884; January 22, 2018; 10.1038/s41388-017-0027-9 Abstract | Full Text CRTC1-MAML2 fusion-induced lncRNA LINC00473 expression maintains the growth and survival of human mucoepidermoid carcinoma cells Zirong Chen, Shuibin Lin, Jian-Liang Li, Wei Ni, Ruifeng Guo et al. Oncogene 2018 37 :1885 - 1895; January 22, 2018; 10.1038/s41388-017-0104-0 Abstract | Full Text Growth arrest and apoptosis induction in androgen receptor-positive human breast cancer cells by inhibition of USP14-mediated androgen receptor deubiquitination Yuning Liao, Xiaohong Xia, Ningning Liu, Jianyu Cai, Zhiqiang Guo et al. Oncogene 2018 37 :1896 - 1910; January 22, 2018; 10.1038/s41388-017-0069-z Abstract | Full Text A Carcinogen-induced mouse model recapitulates the molecular alterations of human muscle invasive bladder cancer Damiano Fantini, Alexander P. Glaser, Kalen J. Rimar, Yiduo Wang, Matthew Schipma et al. Oncogene 2018 37 :1911 - 1925; January 25, 2018; 10.1038/s41388-017-0099-6 Abstract | Full Text The miR-17/92 cluster is involved in the molecular etiology of the SCLL syndrome driven by the BCR-FGFR1 chimeric kinase Tianxiang Hu, Yating Chong, Haiyan Qin, Eiko Kitamura, Chang-Sheng Chang et al. Oncogene 2018 37 :1926 - 1938; January 25, 2018; 10.1038/s41388-017-0091-1 Abstract | Full Text Brief Communications The tumor suppressor Hic1 maintains chromosomal stability independent of Tp53 Anette Szczepny, Kirstyn Carey, Lisa McKenzie, W. Samantha N. Jayasekara, Fernando Rossello et al. Oncogene 2018 37 :1939 - 1948; January 25, 2018; 10.1038/s41388-017-0022-1 Abstract | Full Text Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Oncogene. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Springer Nature |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA Springer Nature's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW. © 2018 Macmillan Publishers Limited, part of Springer Nature. All Rights Reserved.